| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Shanghai Allist Pharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥44.98 |
| 52 Week High | CN¥68.87 |
| 52 Week Low | CN¥29.80 |
| Beta | 0.50 |
| 11 Month Change | -13.23% |
| 3 Month Change | -28.57% |
| 1 Year Change | 46.95% |
| 33 Year Change | 55.53% |
| 5 Year Change | n/a |
| Change since IPO | 16.68% |
Recent News & Updates
Recent updates
Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 30
Should You Be Adding Shanghai Allist Pharmaceuticals (SHSE:688578) To Your Watchlist Today?
Apr 01Optimistic Investors Push Shanghai Allist Pharmaceuticals Co., Ltd. (SHSE:688578) Shares Up 26% But Growth Is Lacking
Mar 04Shareholder Returns
| 688578 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.0% | -1.7% | -2.4% |
| 1Y | 46.9% | -10.7% | -20.1% |
Return vs Industry: 688578 exceeded the CN Pharmaceuticals industry which returned -10.7% over the past year.
Return vs Market: 688578 exceeded the CN Market which returned -20.1% over the past year.
Price Volatility
| 688578 volatility | |
|---|---|
| 688578 Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 688578's share price has been volatile over the past 3 months.
Volatility Over Time: 688578's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,044 | Jinhao Du | www.allist.com.cn |
Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. It offers pharmaceuticals for the treatment of tumor and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.
Shanghai Allist Pharmaceuticals Co., Ltd. Fundamentals Summary
| 688578 fundamental statistics | |
|---|---|
| Market cap | CN¥20.19b |
| Earnings (TTM) | CN¥1.09b |
| Revenue (TTM) | CN¥2.85b |
18.5x
P/E Ratio7.1x
P/S RatioIs 688578 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688578 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.85b |
| Cost of Revenue | CN¥147.72m |
| Gross Profit | CN¥2.70b |
| Other Expenses | CN¥1.61b |
| Earnings | CN¥1.09b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.43 |
| Gross Margin | 94.81% |
| Net Profit Margin | 38.37% |
| Debt/Equity Ratio | 0% |
How did 688578 perform over the long term?
See historical performance and comparison